Correction of insulin resistance and hyperandrogenism in polycystic ovary syndrome by combined rosiglitazone and clomiphene citrate therapy. [electronic resource]
Producer: 20031003Description: 99-104 p. digitalISSN:- 1071-5576
- Adult
- Area Under Curve
- Clomiphene -- therapeutic use
- Drug Therapy, Combination
- Estrogen Antagonists -- therapeutic use
- Female
- Follicle Stimulating Hormone -- blood
- Humans
- Hyperandrogenism -- complications
- Hypoglycemic Agents -- therapeutic use
- Insulin Resistance
- Insulin-Like Growth Factor Binding Protein 3 -- blood
- Insulin-Like Growth Factor I -- drug effects
- Luteinizing Hormone -- blood
- Menstruation
- Polycystic Ovary Syndrome -- complications
- Rosiglitazone
- Thiazoles -- therapeutic use
- Thiazolidinediones
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.